Sobre este podcast
A frequent intelligence briefing from Plocamium Holdings. We turn our Global Insights research and proprietary signal analysis into concise audio editions on geopolitics, markets, private equity, and healthcare, built for decision-makers who move before consensus.
Episodios
Los 20 episodios más recientes de 64
- Panama: The Three-Body Problem · 18 minCanal, Copper, and Climate at the Western Hemisphere's Most Contested Chokepoint — Three forces are converging on Panama simultaneously: a U.S.-China proxy battle over port…
- The Contrarian Case for Costa Rica: Why Smart Capital Is Quietly Flowing Into Central America's Only OECD Economy · 9 minCosta Rica became the first Central American nation admitted to the OECD in 2021 — a milestone that required years of regulatory, governance, and transparency reforms. In 2025…
- The Nearshoring Arbitrage: Why Mexican Manufacturing Is Underpriced by 24% · 6 minIn 2024, Mexico became the United States' largest trading partner for the second consecutive year—$840 billion in total trade, the highest annual total any country has ever…
- 2026: Geopolitics as an Operating Variable · 5 minGeopolitics isn’t a headline risk anymore. It’s an operating variable. As we move through 2025–2026, U.S. healthcare and industrial companies are being shaped less by demand…
- Private Equity Goes on Offense in Defense: A Strategic Shift Accelerates · 4 minIn a development few could have predicted even a few years ago, private equity firms are ramping up investments into the defense sector — traditionally considered off-limits for…
- Mallinckrodt and Endo Merge in $6.7 Billion Deal: Implications for Manufacturing and Financial Strategy · 6 minOne of the most significant effects of the merger will be the integration of both companies’ manufacturing capabilities. Mallinckrodt, historically known for its expertise in…
- AI Infrastructure: The Silent Engine Behind Healthcare’s Next Transformation · 6 minMeta’s ongoing discussions with Apollo Global Management to secure a $35 billion financing package for U.S. data centers offer a glimpse into a larger capital cycle—one that…
- Blackstone’s $5.6 Billion Energy Transition Bet: The Crossroads of Healthcare, Industrials, and Infrastructure · 5 minPlocamium has previously discussed energy transition as part of a broader industrial transformation—one that does not operate in isolation but rather converges with advancements…
- Manufacturing as Healthcare’s Next Competitive Advantage: The Strategic Implications of Eli Lilly’s $27 Billion Investment · 4 minWe’ve long recognized that manufacturing is not just an operational necessity—it is the foundation of sustainable growth, resilience, and innovation. Healthcare companies that…
- Private Equity’s Playbook for Healthcare Contract Manufacturing: The DCC Healthcare Opportunity · 3 minThe healthcare industry is undergoing a profound transformation, shaped by stringent regulatory requirements, shifting demographic trends, and the increasing need for outsourced…
- AI-Powered Drug Repurposing: A New Era for Pharma Manufacturing, CDMOs and CMOs · 5 minManufacturing is no longer just about scale—it's about adaptability. AI-driven drug repurposing is reshaping how CDMOs and CMOs operate, demanding faster, more flexible…
- The High-Stakes Battle for Gland Pharma: A Pivotal Shift in Global Pharma Manufacturing · 4 minFosun’s decision to exit Gland Pharma comes at a time when scrutiny of China-dependent supply chains has never been higher. Acquiring Gland Pharma represents more than just…
- The Impact of Bain Capital’s Acquisition of Apleona on the Healthcare Sector · 4 minHealthcare facilities management is a critical but often underappreciated component of the industry’s infrastructure. Hospitals, clinics, and long-term care facilities rely on…
- Lynn Good on Tariffs: Implications for Trade, Data Centers, and Life Sciences · 3 minIn a recent discussion, Lynn Good, CEO of Duke Energy, offered a strategic perspective on the latest round of proposed tariffs. Rather than viewing them as purely protectionist…
- The Climate-Tech M&A Boom: Scaling the Future of Energy · 4 minThe climate-tech sector is undergoing a massive shift, with M&A leading the charge. Last year alone, we saw nearly $80 billion in climate-tech deals across more than 300…
- Novartis' $3.1 Billion Pipeline Reintegration: A New Model for Pharma M&A? · 5 minNovartis’ recent $3.1 billion acquisition of Anthos Therapeutics is more than just a transaction—it’s a strategic pipeline reintegration move that could signal a new era in…
- France’s €109 Billion AI Investment: A Bold Gamble or a Strategic Necessity? · 3 minFrance is making a high-stakes move in the global AI race, announcing a staggering €109 billion in AI investments. This initiative, championed by President Emmanuel Macron, isn’t…
- The Trump Administration's Deregulation Agenda: Implications for Healthcare · 4 minHow the Trump administration's deregulation push could reshape healthcare policy, from Medicaid home-health rules to private equity investment opportunities in the sector.
- KKR’s Cotiviti-Edifecs Deal: A Masterclass in Financial Engineering or a Risk-Laden Bet? · 4 minThis isn’t just another healthcare technology deal—it’s a microcosm of how today’s private markets are pushing the boundaries of leverage and financial structuring. But the key…
- Pfizer’s Capital Strategy in 2025: Navigating Debt, M&A, and Market Pressures Amid a Healthcare Dealmaking Boom · 4 minPfizer Inc. (NYSE: PFE) stands at a financial crossroads, balancing its capital allocation priorities between business development (BD), debt management, and shareholder returns.








